These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11763240)

  • 1. In-frame fusion of a His-Cys motif into the Pseudomonas aeruginosa outer membrane OprI lipoprotein results in increased metal binding capacity by Escherichia coli.
    Bouia A; Kholti A; Saghi M; Cornelis P
    Res Microbiol; 2001 Nov; 152(9):799-804. PubMed ID: 11763240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key Residues of Outer Membrane Protein OprI Involved in Hexamer Formation and Bacterial Susceptibility to Cationic Antimicrobial Peptides.
    Chang TW; Wang CF; Huang HJ; Wang I; Hsu ST; Liao YD
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6210-22. PubMed ID: 26248382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Production of hybrid protein OprF-OprL of Pseudomonas aeruginosa].
    Kaloshin AA; Mikhaĭlova NA; Leonova EI
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (3):35-43. PubMed ID: 22830272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
    Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
    J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa outer membrane lipoprotein I gene: molecular cloning, sequence, and expression in Escherichia coli.
    Duchêne M; Barron C; Schweizer A; von Specht BU; Domdey H
    J Bacteriol; 1989 Aug; 171(8):4130-7. PubMed ID: 2502533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new membrane-bound OprI lipoprotein expression vector. High production of heterologous fusion proteins in gram (-) bacteria and the implications for oral vaccination.
    Cote-Sierra J; Jongert E; Bredan A; Gautam DC; Parkhouse M; Cornelis P; De Baetselier P; Revets H
    Gene; 1998 Oct; 221(1):25-34. PubMed ID: 9852946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new cloning system based on the OprI lipoprotein for the production of recombinant bacterial cell wall-derived immunogenic formulations.
    Basto AP; Piedade J; Ramalho R; Alves S; Soares H; Cornelis P; Martins C; Leitão A
    J Biotechnol; 2012 Jan; 157(1):50-63. PubMed ID: 22115954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of new cloning vectors for the production of immunogenic outer membrane fusion proteins in Escherichia coli.
    Cornelis P; Sierra JC; Lim A; Malur A; Tungpradabkul S; Tazka H; Leitão A; Martins CV; di Perna C; Brys L; De Baetseller P; Hamers R
    Biotechnology (N Y); 1996 Feb; 14(2):203-8. PubMed ID: 9636324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Display of functionally active PHB depolymerase on Escherichia coli cell surface.
    Hiraishi T; Yamashita K; Sakono M; Nakanishi J; Tan LT; Sudesh K; Abe H; Maeda M
    Macromol Biosci; 2012 Feb; 12(2):218-24. PubMed ID: 22095689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli.
    Finke M; Duchêne M; Eckhardt A; Domdey H; von Specht BU
    Infect Immun; 1990 Jul; 58(7):2241-4. PubMed ID: 2114360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel inner membrane retention signals in Pseudomonas aeruginosa lipoproteins.
    Lewenza S; Mhlanga MM; Pugsley AP
    J Bacteriol; 2008 Sep; 190(18):6119-25. PubMed ID: 18641140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hybrid outer membrane protein antigen for vaccination against Pseudomonas aeruginosa.
    Gabelsberger J; Knapp B; Bauersachs S; Enz UI; von Specht BU; Domdey H
    Behring Inst Mitt; 1997 Feb; (98):302-14. PubMed ID: 9382754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on Construction of Recombinant Bb-pGEX-
    Liu X; Li WG; Luo GX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):13-17. PubMed ID: 29737082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide analysis and literature-based survey of lipoproteins in Pseudomonas aeruginosa.
    Remans K; Vercammen K; Bodilis J; Cornelis P
    Microbiology (Reading); 2010 Sep; 156(Pt 9):2597-2607. PubMed ID: 20616104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane lipoprotein genes, oprI and oprL.
    De Vos D; Lim A; Pirnay JP; Struelens M; Vandenvelde C; Duinslaeger L; Vanderkelen A; Cornelis P
    J Clin Microbiol; 1997 Jun; 35(6):1295-9. PubMed ID: 9163432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence diversity of the oprI gene, coding for major outer membrane lipoprotein I, among rRNA group I pseudomonads.
    De Vos D; Bouton C; Sarniguet A; De Vos P; Vauterin M; Cornelis P
    J Bacteriol; 1998 Dec; 180(24):6551-6. PubMed ID: 9851998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.
    Zhang M; Sun C; Gu J; Yan X; Wang B; Cui Z; Sun X; Tong C; Feng X; Lei L; Han W
    Microbiol Immunol; 2015 Sep; 59(9):533-44. PubMed ID: 26249788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins.
    von Specht BU; Knapp B; Muth G; Bröker M; Hungerer KD; Diehl KD; Massarrat K; Seemann A; Domdey H
    Infect Immun; 1995 May; 63(5):1855-62. PubMed ID: 7729895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Obtaining of outer membrane protein I of Pseudomonas aeruginosa and assessment of its antigenic properties].
    Gatypova EV; Zlygostev SA; Kaloshin AA; Mikhaĭlova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (6):50-3. PubMed ID: 19189463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.
    Mansouri E; Gabelsberger J; Knapp B; Hundt E; Lenz U; Hungerer KD; Gilleland HE; Staczek J; Domdey H; von Specht BU
    Infect Immun; 1999 Mar; 67(3):1461-70. PubMed ID: 10024596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.